Format

Send to:

Choose Destination
See comment in PubMed Commons below
Diagn Microbiol Infect Dis. 2014 Feb;78(2):199-200. doi: 10.1016/j.diagmicrobio.2013.10.012. Epub 2013 Oct 22.

Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin.

Author information

  • 1Infectious Disease Service Brooke Army Medical Center, Houston, TX, USA. Electronic address: anthony.p.cardile.mil@mail.mil.
  • 2Department of Medicine University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • 3Department of Microbiology University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • 4Department of Medicine University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Department of Microbiology University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Department of Pathology University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Abstract

Carbapenem-resistant Enterobacteriaceae infections are becoming more common, are associated with high mortality rates, and are difficult to treat due to multiple mechanisms of resistance. We describe the successful treatment of Klebsiella pneumoniae carbapenemase-expressing Enterobacter cloacae empyema in a lung transplant recipient with cefepime and levofloxacin.

© 2013.

KEYWORDS:

Carbapenemase; Empyema; Enterobacter cloacae; KPC

PMID:
24268534
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk